Updated Jul 16, 2026
VAN NOSTRAND ROBERT L is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $15K.
Robert Van L. Nostrand is a corporate director associated with SELLAS Life Sciences Group, Inc. and Intra-Cellular Therapies, Inc. He has been involved in the biopharmaceutical sector, particularly focusing on cancer therapeutics.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-06-12 | SLS | SELLAS Life Sciences Group, Inc. | P — Open-market purchase | 10.0K | $1.48 | $15K |
| 2025-04-02 | ITCI | Intra-Cellular Therapies, Inc. | D — Derivative transaction | 11.3K | $132.00 | $1.50M |
Robert Van L. Nostrand is a corporate director associated with SELLAS Life Sciences Group, Inc. and Intra-Cellular Therapies, Inc. He has been involved in the biopharmaceutical sector, particularly focusing on cancer therapeutics.…
Recorded transactions: 1 open-market purchases ($15K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live VAN NOSTRAND ROBERT L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.